miRoncol Diagnostics
Bioinformatics
Multicancer early detection
Rna
Cancer screening
Liquid biopsy
Medical practice
Founded in 2022
Philadelphia, Pennsylvania
miRoncol Diagnostics information
miRoncol's mission is to transform early-stage cancer screening and save lives from cancer. miRoncol invented a blood test for Multi-Cancer Early Detection (MCED). As a cancer screening tool, miRoncol's test will be highly accurate, highly affordable, and highly accessible and can be run on ubiquitous RT-qPCR equipment. miRoncol is currently dedicated to commercializing its disruptive invention.
Employees
Looking for a particular miRoncol Diagnostics Employee?
Employee Metrics
miRoncol Diagnostics' financial review
Employees
4
Technologies
Gmail
Email Providers
Google Apps
Other
Google Cloud Hosting
Hosting
Varnish
Load Balancers
Wix
CMS
Mobile Friendly
Other
Employees
Looking for a particular miRoncol Diagnostics Employee?
miRoncol Diagnostics' financial review
Employees
4
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
